Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$44,619,340
+$2,453,285 QoQ
Shares Held
123,217
+2.8% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#229
of 3,140 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $337,469,957 across 15 Drug Manufacturers - General names. AMGN ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,682 | $94,373,559 | |
| 2 | JNJ |
Johnson & Johnson
|
183,113 | $46,505,208 | |
| 3 | AMGN |
Amgen Inc
This page
|
123,217 | $44,619,340 | |
| 4 | ABBV |
AbbVie Inc.
|
161,999 | $40,765,428 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
259,210 | $32,748,591 | |
| 6 | MRK |
Merck & Co., Inc.
|
184,897 | $23,759,264 | |
| 7 | PFE |
Pfizer Inc
|
809,970 | $19,504,077 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
254,808 | $14,682,036 |
All Filings in AMGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,619,340 | 123,217 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $42,166,055 | 119,841 | Shares | Sole | 2026-04-24 | |
| 2025-09-30 | $31,923,310 | 113,123 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $30,995,660 | 111,012 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $34,218,471 | 109,833 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $28,974,827 | 111,168 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $39,487,479 | 122,552 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $38,630,693 | 123,638 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $34,446,789 | 121,155 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $32,339,173 | 112,281 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $29,259,363 | 108,868 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $23,582,298 | 106,217 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $25,251,754 | 104,454 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $23,008,839 | 87,606 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $21,157,171 | 93,865 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,504,033 | 92,495 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $23,042,544 | 95,288 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $21,919,052 | 97,431 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $19,707,976 | 92,678 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $22,907,381 | 93,979 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $23,020,398 | 92,522 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $19,001,278 | 82,643 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $21,202,535 | 83,422 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $22,750,819 | 96,459 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $23,063,578 | 113,765 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||